Haberer Registered Investment Advisor’s Pfizer PFE Stock Holding History

Haberer Registered Investment Advisor’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$787K	Buy	23,847 +2,039	+9%	+$64.8K	0.48%	47
2014 Q4	$645K	Sell	21,808 -5,185	-19%	-$149K	0.37%	56
2014 Q3	$757K	Sell	26,993 -11,670	-30%	-$328K	0.36%	57
2014 Q2	$1.09M	Sell	38,663 -4,050	-9%	-$115K	0.48%	52
2014 Q1	$1.3M	Sell	42,713 -4,111	-9%	-$123K	0.63%	43
2013 Q4	$1.36M	Sell	46,824 -4,442	-9%	-$129K	0.57%	49
2013 Q3	$1.4M	Sell	51,266 -8,729	-15%	-$238K	0.5%	52
2013 Q2	$1.59M	Buy	+59,995	New	+$1.66M	0.44%	50

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Haberer Registered Investment Advisor's PFE Position: Q1 2015 in Review

Haberer Registered Investment Advisor increased its Pfizer (PFE) stake by 9.3% in Q1 2015, buying an estimated $64.8K and bringing the position to 23,847 shares worth $787K. The position accounts for 0.48% of the portfolio, ranked #47.

Haberer Registered Investment Advisor first reported a position in PFE in Q2 2013 and has held it in 8 quarters since. The position peaked at $1.59M in Q2 2013. 1,875 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

Haberer Registered Investment Advisor held 23,847 shares of Pfizer worth $787K as of Q1 2015.
Haberer Registered Investment Advisor bought 2,039 Pfizer shares in Q1 2015, an estimated $64.8K.
Pfizer made up 0.48% of Haberer Registered Investment Advisor's portfolio in Q1 2015, its #47 holding.
Haberer Registered Investment Advisor first reported a position in Pfizer in Q2 2013 and has held it in 8 quarters since.
Haberer Registered Investment Advisor's Pfizer position peaked at $1.59M in Q2 2013.
1,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Haberer Registered Investment Advisor's 13F filing for Q1 2015, filed 8 Apr 2015.